1994
DOI: 10.1006/geno.1994.1562
|View full text |Cite
|
Sign up to set email alerts
|

Structure and Chromosomal Localization of the Human PD-1 Gene (PDCD1)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
137
0
10

Year Published

1999
1999
2007
2007

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 212 publications
(147 citation statements)
references
References 0 publications
0
137
0
10
Order By: Relevance
“…Programmed cell death 1 (PD-1, CD279) is a type 1 transmembrane protein containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM) [1], which is induced upon the activation of CD4 and CD8 T cells as well as B, NKT and myeloid cells [2]. PD-1 has two ligands, PD-L1 (also known as B7-H1 or CD274), constitutively expressed by many tissues and upregulated on activation [3], and PD-L2 (also known as B7-DC or CD273), expressed primarily by activated DC and macrophages [4].…”
Section: Introductionmentioning
confidence: 99%
“…Programmed cell death 1 (PD-1, CD279) is a type 1 transmembrane protein containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM) [1], which is induced upon the activation of CD4 and CD8 T cells as well as B, NKT and myeloid cells [2]. PD-1 has two ligands, PD-L1 (also known as B7-H1 or CD274), constitutively expressed by many tissues and upregulated on activation [3], and PD-L2 (also known as B7-DC or CD273), expressed primarily by activated DC and macrophages [4].…”
Section: Introductionmentioning
confidence: 99%
“…It is a 50-55-kDa receptor with 23% identity to CTLassociated antigen-4 (CTLA-4) in its Ig domain [7], and is expressed on activated, but not resting, CD4 + and CD8 + T cells, B cells, and myeloid cells [8]. PD-1 has an immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain [9][10][11]. Depending on background strain, PD-1 -/-mice develop increased rates of glomerulonephritis, lupus-like arthritis [12], or autoimmune cardiomyopathy [13].…”
Section: Introductionmentioning
confidence: 99%
“…À ce jour, trois entités ont été décrites : CTLA-4, PD-1 et BTLA [14][15][16]. Ces molécules sont toutes impliquées dans le contrôle de la tolérance, en déclenchant des seconds signaux inhibiteurs qui vont empêcher, terminer ou atténuer une réponse immune.…”
Section: Corécepteurs Co-inhibiteursunclassified